Tempus AI, Inc. (NASDAQ:TEM) is one of the stocks Jim Cramer looked at recently. When a caller asked if the stock is a buy, sell, or hold, Cramer said:
Well, you know we’re not recommending stocks that are losing a lot of money here just because the year of magical investing made a return, and I think that you got a little reprieve, and it’s going to go back down again.
Tempus AI, Inc. (NASDAQ:TEM) develops technology that organizes and analyzes large amounts of clinical and molecular data to help doctors personalize patient care. The company’s platform uses AI to run diagnostic tests, match patients with clinical trials, and assist pharmaceutical companies in discovering new cancer treatments in strategic partnerships with companies like AstraZeneca and Pathos AI. A caller asked about the stock during the July 9, 2025, episode and Cramer replied:
Okay, another company that’s just losing money hand over fist. I just can’t go there. You know, when it comes to AI, you know what I believe in? I believe in NVIDIA.
It is worth noting that the company’s stock is down nearly 6% from the day the above comment was aired.
While we acknowledge the potential of TEM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
Disclosure: None. This article is originally published at Insider Monkey.
